{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T22:57:07Z","timestamp":1791154627806,"version":"4.1.0"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[1999,9,1]],"date-time":"1999-09-01T00:00:00Z","timestamp":936144000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[1999,9,1]],"date-time":"1999-09-01T00:00:00Z","timestamp":936144000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharm Res"],"published-print":{"date-parts":[[1999,9]]},"DOI":"10.1023\/a:1018986605929","type":"journal-article","created":{"date-parts":[[2003,2,19]],"date-time":"2003-02-19T17:07:13Z","timestamp":1045674433000},"page":"1352-1359","source":"Crossref","is-referenced-by-count":51,"title":["Transport and Metabolic Characterization of Caco-2 Cells Expressing CYP3A4 and CYP3A4 Plus Oxidoreductase"],"prefix":"10.1007","volume":"16","author":[{"given":"Ming","family":"Hu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiqi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine M.","family":"Davitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiew-Mei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth","family":"Thummel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce W.","family":"Penman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles L.","family":"Crespi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"303670_CR1","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/0006-291X(91)91647-U","volume":"175","author":"P. Artursson","year":"1991","unstructured":"P. Artursson and J. Karlsson. Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells. Biochem. Biophys. Res. Commun.\n175:880-885 (1991).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"303670_CR2","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1021\/js9803205","volume":"88","author":"J. D. Irvine","year":"1999","unstructured":"J. D. Irvine, L. Takahashi, K. Lockhart, J. Cheong, J. W. Tolan, H. E. Selick, and J. R. Grove. MDCK (Madin-Darby canine kidney) cells: A tool for membrane permeability screening. J. Pharm. Sci.\n88:28-33. (1999).","journal-title":"J. Pharm. Sci."},{"key":"303670_CR3","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1023\/A:1016428304366","volume":"13","author":"C. L. Crespi","year":"1996","unstructured":"C. L. Crespi, B. W. Penman, and M. Hu. (1996) The development of Caco-2 cells expressing high levels of cDNA-derived cytochrome P4503A4. Pharm. Res.\n13:1635-1641 (1996).","journal-title":"Pharm. Res."},{"key":"303670_CR4","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/S0090-9556(25)07353-2","volume":"24","author":"L. S. L. Gan","year":"1996","unstructured":"L. S. L. Gan, M. A. Moseley, B. Khosla, P. F. Augustijns, T. P. Bradshaw, R. W. Hendren, and D. R. Thakker. CYP3A-like cytochrome p-450-mediated metabolism and polarized efflux of cyclosporin A in Caco-2 cells: Interaction between the two biochemical barriers to intestinal transport. Drug Metab. and Disp.\n24:344-349 (1996).","journal-title":"Drug Metab. and Disp."},{"key":"303670_CR5","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1016\/0140-6736(91)92302-I","volume":"338","author":"J. C. Kolars","year":"1991","unstructured":"J. C. Kolars, W. M. Awni, R. M. Merion, and P. B. Watkins. First-pass metabolism of cyclosporin by the gut. Lancet\n338:1488-1490 (1991).","journal-title":"Lancet"},{"key":"303670_CR6","first-page":"119","volume":"1","author":"D. J. Back","year":"1987","unstructured":"D. J. Back and S. M. Rogers. First pass metabolism by the gastrointestinal mucosa. Alimen. Pharmacol. Ther.\n1:119-157 (1987).","journal-title":"Alimen. Pharmacol. Ther."},{"key":"303670_CR7","doi-asserted-by":"crossref","first-page":"144","DOI":"10.2165\/00003088-199426020-00007","volume":"26","author":"D. R. Krishna","year":"1994","unstructured":"D. R. Krishna and U. Klotz. Extrahepatic metabolism of drugs in humans. Clin. Pharmacokinet.\n26:144-160 (1994).","journal-title":"Clin. Pharmacokinet."},{"key":"303670_CR8","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1097\/00008571-199706000-00005","volume":"7","author":"C. L. Crespi","year":"1997","unstructured":"C. L. Crespi and V. P. Miller. The R144C change in the CYP2C9*2 allele alters interaction of the cytochrome P450 with NADPH cytochrome P450 oxidoreductase. Pharmacogenetics\n7:203-210 (1997).","journal-title":"Pharmacogenetics"},{"key":"303670_CR9","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1023\/A:1018935704693","volume":"11","author":"M. Hu","year":"1994","unstructured":"M. Hu, J. Chen, Y. Zhu, A. H. Dantzig, R. E. Stratford, and M. T. Kuhfeld. Mechanism and kinetics of transcellular transport of a new \u03b2-lactam antibiotic loracarbef across an human intestinal epithelial model system (Caco-2). Pharm. Res.\n11:1405-1413 (1994).","journal-title":"Pharm. Res."},{"key":"303670_CR10","doi-asserted-by":"crossref","first-page":"291","DOI":"10.3109\/10611869509015958","volume":"3","author":"M. Hu","year":"1995","unstructured":"M. Hu, L. Zheng, J. Chen, L. Liu, Y. Li, A. H. Dantzig, and R. E. Stratford. Peptide transporter function and prolidase activities in Caco-2 cells: a lack of coordinated expression. J. Drug Target.\n3:291-300 (1995).","journal-title":"J. Drug Target."},{"key":"303670_CR11","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1023\/A:1016247523311","volume":"12","author":"M. Hu","year":"1995","unstructured":"M. Hu, L. Zheng, J. Chen, L. Liu, Y. Zhu, A. H. Dantzig, R. E. Stratford. Mechanisms of transport of quinapril in Caco-2 cell monolayers: comparison with cephalexin. Pharm. Res.\n12:1120-1125 (1995).","journal-title":"Pharm. Res."},{"key":"303670_CR12","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1097\/00008571-199302000-00003","volume":"3","author":"B. W. Penman","year":"1993","unstructured":"B. W. Penman, J. Reece, T. Smith, C. S. Yang, H. V. Gelboin, F. J. Gonzalez, and C. L. Crespi. Characterization of a human cell line expressing high levels of cDNA-derived CYP2D6. Pharmacogenetics\n3:28-39 (1993).","journal-title":"Pharmacogenetics"},{"key":"303670_CR13","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/0014-5793(94)01199-0","volume":"355","author":"V. Carrier","year":"1994","unstructured":"V. Carrier, T. Lesuffleur, A. Barbat, M. Rousset, E. Dussaulx, P. Costet, I. Dewaziers, P. Beaune, and A. Zweibaum. Expression of cytochrome P450 3A in HT29-MTX and Caco-2 cell clone TC7. FEBS Letters. 355:247-250 (1994).","journal-title":"FEBS Letters"},{"key":"303670_CR14","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/S0090-9556(25)06500-6","volume":"23","author":"D. J. Newton","year":"1995","unstructured":"D. J. Newton, R. W. Wang, and A. Y. H. Lu. Cytochrome P450 inhibitors: Evaluation of specificities in the in vitro metabolism of therapeutic agents by human liver microsomes. Drug Metab. Disp.\n23:154-158 (1995).","journal-title":"Drug Metab. Disp."},{"key":"303670_CR15","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0090-9556(25)08308-4","volume":"22","author":"S. Diamond","year":"1994","unstructured":"S. Diamond, D. Rakestraw, J. O'Neil, G. N. Lam, and D. D. Christ. Induction of cytochromes P-450 2B and 3A in mice following the dietary administration of the novel cognitive enhancer linopirdine. Drug Metab. Disp.\n22:65-73 (1994).","journal-title":"Drug Metab. Disp."},{"key":"303670_CR16","first-page":"1","volume":"5","author":"L. Grushkin-Lerner","year":"1995","unstructured":"L. Grushkin-Lerner. The use of PET membranes for the study of cells for electron microscopy. The Cell Line.\n5:1-2 (1995).","journal-title":"The Cell Line."},{"key":"303670_CR17","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/0092-8674(85)90192-8","volume":"40","author":"P. A. Jones","year":"1985","unstructured":"P. A. Jones. Altering gene expression with 5-azacytidine. Cell 40:485-486 (1985).","journal-title":"Cell"}],"container-title":["Pharmaceutical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1018986605929.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1023\/A:1018986605929\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1018986605929.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T07:38:29Z","timestamp":1754033909000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1023\/A:1018986605929"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,9]]},"references-count":17,"journal-issue":{"issue":"9","published-print":{"date-parts":[[1999,9]]}},"alternative-id":["303670"],"URL":"https:\/\/doi.org\/10.1023\/a:1018986605929","relation":{},"ISSN":["0724-8741","1573-904X"],"issn-type":[{"value":"0724-8741","type":"print"},{"value":"1573-904X","type":"electronic"}],"subject":[],"published":{"date-parts":[[1999,9]]}}}